THC Tenet Healthcare Corporation
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.…
Industry Peers
Medical Care FacilitiesKey Statistics
About Tenet Healthcare (NYSE: THC)
›
Tenet Healthcare (NYSE: THC) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 77,000 employees.
The shares were at 263.59 USD on 19 November 2026, up 36.6% over 52 weeks. Its 52-week range is 157.58 USD to 301.44 USD: the price is 12.6% below the high and 67.3% above the low.
At a market capitalisation of 20.98B USD, it trades at 7.7 times trailing earnings and 13.0 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.7, a discount of 68% for THC.
Tenet Healthcare reports return on equity of 33.3%, an operating margin of 19.1% and revenue up 6.5% year over year.
Its debt exceeds its cash by 10.57B USD, a debt-to-equity ratio of 3.12. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 22 analysts cover the stock, with an average rating of Buy; their mean price target of 308.91 USD is 17.2% above the current price. The next earnings report is expected on 10 February 2027.